Percentage of cancers in England diagnosed at stage I or II

  • Public Health England

  • curated by Dawn O'Shea
  • Medical news
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

In England in 2018, 55% of cancers diagnosed and recorded as stage I-IV were recorded as stages I and II, ranging from 48% in some Clinical Commissioning Groups (CCGs) to 64% in others. The figures, released by Public Health England (PHE), are comparable to the previous year (2017) when the unadjusted percentage was 54%, ranging from 47% to 60%.

The percentage of cancers diagnosed at stages I and II varied by cancer site and ranged from 13.5% of cancers of the oropharynx, base of tongue, tonsil, soft palate and uvula to 92.0% of testicular cancers.

More than 75% of the following cancers were diagnosed at stage I or II: melanoma (89.2%), thyroid (88.9%), breast (85.8%), uterus (80.8%), cervix (80.3%) and bladder (75.8%).

The percentages for renal (except renal pelvis), prostate, and the laryngeal cancers (including anterior surface of the epiglottis) were 56.9%, 54.6%, and 50.9%, respectively.

Of cancers of the oral cavity, hard palate and lip (inner aspect), 46.5% were diagnosed at stage I or II, similar to percentages for Hodgkin lymphoma (45.2%) and cancer of the colon (45.0%) and the rectum and rectosigmoid junction (43.0%). Forty per cent of cancer of the ovary or fallopian tube and primary peritoneal carcinomas were diagnosed at stage I or II. This dropped to 30% for non-Hodgkin lymphoma.

Percentages fell to below 30 for cancers of the lung (28.9%), stomach excluding cardia and gastroesophageal junction (27.4%), pancreas (22.6%), and the oesophagus including cardia and gastroesophageal junction (21.5%).

The data suggest there is a need for greater awareness of the early symptoms and signs of some common cancers.